| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 1,610,000 | 1,594,000 | 1,674,000 | 1,407,000 | | Cost of Revenue | 300,000 | 346,000 | 347,000 | 347,000 | | | Gross Profit | 1,310,000 | 1,248,000 | 1,327,000 | 1,060,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 750,000 | 834,000 | 762,000 | 781,000 | | Non Recurring | 223,000 | 469,000 |
-
|
-
| | Others | 961,000 | 626,000 | 461,000 | 619,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (624,000) | (681,000) | 104,000 | (340,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (624,000) | (681,000) | 104,000 | (340,000) | | Interest Expense | 118,000 | 178,000 | 186,000 | 175,000 | | Income Before Tax | (742,000) | (859,000) | (82,000) | (515,000) | | Income Tax Expense | (244,000) | (335,000) | (46,000) | 611,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (498,000) | (524,000) | (36,000) | (1,126,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (498,000) | (524,000) | (36,000) | (1,126,000) | | Preferred Stock And Other Adjustments | (38,000) | (42,000) |
-
|
-
| | | Net Income Applicable To Common Shares | ($536,000) | ($566,000) | ($36,000) | ($1,126,000) |
|
0.45% Nasdaq 
0.20%
Income Statement
